Hugh Bonner

1.9k total citations · 2 hit papers
14 papers, 1.4k citations indexed

About

Hugh Bonner is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Hugh Bonner has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Hugh Bonner's work include Chronic Lymphocytic Leukemia Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Hugh Bonner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Hugh Bonner collaborates with scholars based in United States. Hugh Bonner's co-authors include Costan W. Berard, Robert E. Rydell, Risa B. Mann, Maurice Barcos, John M. Bennett, Richard S. Neiman, Joseph Newall, Diana F. Nelson, Herbert D. Kerman and Karen Martz and has published in prestigious journals such as Cancer, The American Journal of Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hugh Bonner

13 papers receiving 1.4k citations

Hit Papers

Granulocytic sarcoma: A clinicopathologic study of 61 bio... 1981 2026 1996 2011 1981 1992 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases
    1981 745 citations Richard S. Neiman, Maurice Barcos et al. Cancer profile →
  2. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315
    1992 467 citations Diana F. Nelson, Karen Martz et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugh Bonner United States 9 623 577 512 511 267 14 1.4k
AH Goldstone United Kingdom 22 808 1.3× 307 0.5× 166 0.3× 441 0.9× 567 2.1× 50 1.5k
Gerald E. Byrne United States 27 204 0.3× 575 1.0× 504 1.0× 1.4k 2.7× 959 3.6× 48 2.3k
Francis Witz France 19 1.3k 2.1× 430 0.7× 224 0.4× 266 0.5× 414 1.6× 54 2.0k
RK Brynes United States 19 324 0.5× 325 0.6× 117 0.2× 555 1.1× 451 1.7× 37 1.2k
A Bussel France 21 598 1.0× 376 0.7× 160 0.3× 168 0.3× 220 0.8× 82 1.8k
DY Mason United Kingdom 7 216 0.3× 372 0.6× 235 0.5× 1.2k 2.4× 688 2.6× 9 1.8k
Masami Takeuchi Japan 20 425 0.7× 274 0.5× 434 0.8× 551 1.1× 454 1.7× 120 1.4k
A. Le Tourneau France 20 159 0.3× 263 0.5× 94 0.2× 460 0.9× 379 1.4× 83 1.2k
Paul G. Schlegel Germany 23 490 0.8× 376 0.7× 169 0.3× 170 0.3× 600 2.2× 56 1.8k
Laurent Sutton France 26 1.3k 2.1× 728 1.3× 127 0.2× 753 1.5× 1.1k 4.1× 61 2.7k

Countries citing papers authored by Hugh Bonner

Since Specialization
Citations

This map shows the geographic impact of Hugh Bonner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Bonner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Bonner more than expected).

Fields of papers citing papers by Hugh Bonner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Bonner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Bonner. The network helps show where Hugh Bonner may publish in the future.

Co-authorship network of co-authors of Hugh Bonner

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Bonner. A scholar is included among the top collaborators of Hugh Bonner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Bonner. Hugh Bonner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Cherian, Sindhu, Rachel L. Sargent, Raja R. Seethala, et al.. (2005). Expanded Populations of Surface Membrane Immunoglobulin Light Chain–Negative B Cells in Lymph Nodes Are Not Always Indicative of B-Cell Lymphoma. American Journal of Clinical Pathology. 124(1). 143–150. 12 indexed citations
2.
Zhao, Xianfeng, Sindhu Cherian, Rachel L. Sargent, et al.. (2005). Expanded Populations of Surface Membrane Immunoglobulin Light Chain-Negative B Cells in Lymph Nodes Are Not Always Indicative of B-Cell Lymphoma. American Journal of Clinical Pathology. 124(1). 143–150.
3.
Nowell, P C, et al.. (1997). Concurrent diagnosis of chronic lymphocytic leukemia and myelodysplastic syndrome. Leukemia Research. 21(7). 619–621. 8 indexed citations
4.
Nelson, Diana F., Karen Martz, Hugh Bonner, et al.. (1992). Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315. International Journal of Radiation Oncology*Biology*Physics. 23(1). 9–17. 467 indexed citations breakdown →
5.
Spivey, William H, et al.. (1987). Endotracheal diazepam: Absorption and pulmonary pathologic effects. Annals of Emergency Medicine. 16(3). 314–318. 14 indexed citations
6.
Kornstein, Michael J., et al.. (1986). Leu M1 and S100 in Hodgkin’s Disease and Non-Hodgkin’s Lymphomas. American Journal of Clinical Pathology. 85(4). 433–437. 24 indexed citations
7.
Schumacher, H. Ralph, et al.. (1984). Tumor‐like soft tissue swelling of the distal phalanx due to calcium pyrophosphate dihydrate crystal deposition. Arthritis & Rheumatism. 27(12). 1428–1432. 9 indexed citations
8.
Ligler, Frances S., et al.. (1983). Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy. Journal of Clinical Immunology. 3(4). 375–381. 6 indexed citations
9.
Ligler, Frances S., et al.. (1983). Immunoregulatory cell subsets in Goodpasture's syndrome: Evidence for selective T suppressor-cell depletion during active autoimmune disease. Journal of Clinical Immunology. 3(4). 368–374. 3 indexed citations
10.
Neiman, Richard S., Maurice Barcos, Costan W. Berard, et al.. (1981). Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases. Cancer. 48(6). 1426–1437. 745 indexed citations breakdown →
11.
Atkinson, Barbara, et al.. (1977). Rapid Screening for Lupus Erythematosus Ceils Using Cytocentrifuge-prepared Buffy Coat Monolayers. American Journal of Clinical Pathology. 67(6). 537–539. 5 indexed citations
12.
Noone, R. Barrett, et al.. (1974). LYMPH NODE METASTASES IN ORAL CARCINOMA A Correlation of Histopatliology with Survival. Plastic & Reconstructive Surgery. 53(2). 158–166. 71 indexed citations
13.
Bonner, Hugh, et al.. (1974). Cavitating splenic infarction. The American Journal of Medicine. 56(5). 720–724. 5 indexed citations
14.
Bennett, John E., et al.. (1973). Chronic Meningitis Caused byCladosporium trichoides. American Journal of Clinical Pathology. 59(3). 398–407. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by AH Goldstone Breakdown of academic impact, for papers by Gerald E. Byrne Breakdown of academic impact, for papers by Francis Witz Breakdown of academic impact, for papers by RK Brynes Breakdown of academic impact, for papers by A Bussel Breakdown of academic impact, for papers by DY Mason Breakdown of academic impact, for papers by Masami Takeuchi Breakdown of academic impact, for papers by A. Le Tourneau Breakdown of academic impact, for papers by Paul G. Schlegel Breakdown of academic impact, for papers by Laurent Sutton
Rankless by CCL
2026